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ABSTRACT The tumor promoter, phorbol myristate acetate (PMA), stimulates plasminogen
activator production and extracellular release in confluent Swiss 3T3 cells. Coordinated with
the increased extracellular release is a redistribution of the activity into plasma membrane-
enriched fractions and a shift in the predominant molecular weight species from 75,000 to
49,000 daltons. The evidence suggests that PMA induces the formation of the 49,000 dalton
species which is preferentially located in plasma membrane-enriched fractions .
Plasminogen activator (PA) is a serine protease that catalyzes
the conversion ofthe serum zymogen, plasminogen, to plasmin,
the main source of serum fibrinolytic activity. Thus, the pres-
ence of PA allows for potential production oflarge amounts of
extracellular proteolytic activity via plasmin. In addition to its
role in generating plasmin, the possibility that PA acts inde-
pendently of plasmin, in localized cell surface proteolytic
events, remains open (1). The close correlation between the
presence of PA activity and cellular processes involving cell
migration, tissue remodeling, or malignant transformation has
led to the suggestion that PA, through generation of extracel-
lular proteolytic activity, is an important component of these
processes, although the exact role is unknown. Part of the
difficulty in assigning an exact role for PA in cellular processes
may be related to the observation of the existence of several
molecular weight forms. The different molecular weight forms
have been identifiedonly in terms of fibrinolytic activity, and,
because several proteases may be capable of activating plas-
minogen, it is possible that the PA activity being measured in
the fibrinolytic activity is actually a class ofotherwise unrelated
enzymes. These different molecular weight forms may or may
not share similar biological functions.
In the accompanying paper (2), we have demonstrated that
upon mitogenic stimulation of quiescent monolayers of 3T3
cells, there is an apparent increase in the level of a particular
molecular weight species of PA. In addition, this is the predom-
inant species in growing and transformed cells (2). In previous
work, we have demonstrated a difference in subcellular distri-
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bution of PA between quiescent and growing or transformed
3T3 cells (3). We have extended those observations in the
present work by examining the subcellular distribution ofeach
PA species in cells exposed to the potent tumor promoter,
phorbol myristate acetate (PMA).
PMA has been shown to temporarily and reversibly cause
acquisition of several of the properties of the transformed
phenotype, including increased saturation density, decreased
collagen production, decreased cell surface fibronectin, altered
cell morphology, increased omithine decarboxylase, and in-
creased PA (for review, see reference 4). We, therefore, used
PMA to activate cells in order to study those aspects of regu-
lation of PA that may be important in relation to the trans-
formed phenotype. Specifically, we have studied the effect of
PMA on the association of PA with a plasma membrane-
enriched fraction, thus placing PA in an environment in which
it could contribute to extracellular proteolytic activity that may
be important in mediating several properties ofthe transformed
phenotype.
MATERIALS AND METHODS
Materials
Materials were purchased from the following sources: acrylamide from Bio-
Rad Laboratories, Richmond, Calif.; dextran (40,000 daltons) and sucrose from
Schwatz-Mann Div. of Becton, Dickson and Co., Orangeburg, N.Y.); sodium
dodecyl sulfate from British Drug Houses, Ltd., Poole, England; fibrinogen from
The American Red Cross; wheat germ agglutinin from Calbiochem-Bohring
Corp., San Diego, Calif.; all other compounds were from Sigma Chemical Co.,
727St. Louis, Mo. Plasminogen was prepared from human serum as described by
Deutsch and Mertz (5). Fibrinogen was iodinated as described by Helkamp et al.
(6). Wheat germ agglutinin (WGA) was iodinated as described by Stanley and
Carver (7).
Subcellular Fractions
Subcellular fractionation was accomplished using a discontinuous sucrose-
dextran gradient system developed by Graham et al. (S) as described (3).
Recoveries ofprotein, WGA, enzymatic markers and PA were always 100 t20%.
No more than 15% of the PA was lost to the crude nuclear pellet in preparation
ofthe postnuclear supernate.
Sodium Dodecyl Sulfate-Polyacrylamide Gel
Electrophoresis (SDS-PAGE)
The methods are described in the accompanying paper (2).
RESULTS
Stimulation of PA Production with PMA
PMA (100 ng/ml) was added to postconfluent cultures for
the indicated times as shown in Fig. 1. Although lower concen-
trations ofPMA were effective, this concentration of PMA was
used in all experiments because it produced consistent, maxi-
mal effects and was shown not to be toxic to these cells (9).
The results show that, after an initial decrease, PA activity
began to increase at 5 h after exposure. The increase in lysate
activity resulted in increased elaboration of extracellular activ-
ity. These results indicate that PMA mediates increased cell-
associated PA which is followed temporally by increased extra-
cellular activity.
Effect of PMA on Intracellular Distribution of PA
We have previously shown that growing and transformed
PMA-TREATED
cells, which release more PA extracellularly than quiescent
cells, contain PA predominantly in a plasma membrane-en-
riched fraction compared with their quiescent counterparts (3).
Therefore, we examined whether induction of extracellular
release by PMA was accompanied by a shift in intracellular
distribution.
Control and PMA-treated cells (6 h) were processed for
subcellular fractionation (Fig. 2). The distributions of protein,
"'I-WGA (plasma membrane marker), NADH-oxidase (en-
doplasmic reticulum marker), and succinate-cytochrome c re-
ductase (mitochondrial marker) were similar for the control
and PMA-treated cultures. Recovery of protein, all the
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￿
Kinetics of effect of PMA on intracellular and extracel-
lular PA. Confluent monolayers were treated with PMA (100 ng/ml) .
At the indicated times, lysates were collected and parallel cultures
were switched to serum-free medium without PMA. The har-
vest fluids were collected after a 4-h incubation period. Samples
were collected from two separate plates and assayed in triplicate.
* Percentage of hydrolysis per microgram cell protein.
b
2 4 6 8 10 12 14 16 18 20 22 24 26 28
-- 55% -+ 35% + 32% -i22.Ay + 5% -~
SUCROSE SUCROSE SUCROSE ' 1 SUCROSE
% DEXTRAN %SUCROSE
FRACTION NUMBER
FIGURE 2
￿
Subcellular distribution of PA in confluent and PMA-treated cultures. Confluent monolayers were exposed to PMA (100
ng/ml) for 6 h. At this time, treated (a) and untreated (b) cultures were processed for subcellular fractionation as described in
Methods. The specific activity of several marker proteins is included .
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FRACTION NUMBERmarkers, and PA was 100 t 201 1b for each gradient. Recovery
of PA in the lowerportion of the gradient (fractions 1-11) was
69 ± 4% for quiescent cells and 42 ± 6% for PMA-treated cells
(n = 8, P < 0.001, paired Student's t test). Thus, there is a
significant redistribution of PA from the intracellular mem-
brane fractions (55%/35% sucrose interface) to the plasma
membrane-enriched fractions (22.5% dextran/19% sucrose in-
terface) in the PMA-treated cultures. In 13 experiments, there
was a 1 .5- to 4.0-fold increase in specific activity in the plasma
membrane-enriched fractions from PMA-treated relative to
control cultures. The decrease in specific activity in the intra-
cellular membrane fraction shown in Fig. 2 did not always
occur (see Fig. 3, for example).
Time of PMA Exposure for Induction of the
Redistribution of PA
To examine whether there was a temporal correlation be-
tween the increase in specific activity of PA in the plasma
membrane-enriched fractions and the increase in total cellular
PA, confluent monolayers were treated with PMA for various
times and then processed for subcellular fractionation. Each of
the gradient fractions was assayed for protein, 1251-WGA, and
PA. NADH-oxidase and succinate-cytochrome c reductase ac-
tivities were not measured. The protein and 1251-WGA profiles
for each gradient were similar; therefore, only the distribution
of PA is reported (Fig. 3). Within 3 h after exposure to PMA,
there was a decrease in the specific activity of PA in the
postnuclear supernatant fluid (PNsup) and throughout the
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gradient fractions. Between 3 and 6 h, the specific activity in
the PNsup increased. This was accompanied by an increase in
the specific activity in the plasma membrane-enriched fraction.
This increase was maintained, although not maximally, for 24
h, as was the increase in the PNsup. Therefore, between 3 and
6 h, during the time of increasing intracellular activity, there
was an increase in PA in the plasma membrane-enriched
fractions.
Effect of PMA on Molecular Weight of PA
The effect of PMA on the relative amounts ofthe molecular
weight forms of PA is shown in Fig. 5 of the accompanying
paper (2). These data indicate that during the period 3-6 h
after exposure to PMA, which corresponded with increasing
lysate activity (Fig. 1) and increasing plasma membrane-en-
riched gradient fraction activity (Fig. 3), there was an increase
in the 49,000:75,000 dalton PA ratio. In five experiments, the
percentage of the total activity recovered as 75,000 dalton PA
in control vs. PMA-treated samples was 84 t 100 /0 (n = 15) vs.
24 f 8% (n = 13). Within 3 h after exposure to PMA, the
49,000 dalton species became more prominent. Because the
data are expressed in relative terms, the change in ratios could
be explained by a decrease in 75,000 dalton PA or an increase
in 49,000 dalton PA. This point was addressed directly by
comparing the absolute amount of activity recovered as each
species after various times of exposure to PMA (Table I). The
initial decrease in PA lysate activity (3 h, Fig. 1) correlated
with a decrease in 75,000 dalton PA to 59% of control levels.
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FIGURE 3
￿
Kinetics of PMA induction of subcellular redistribution of PA. Confluent monolayers were exposed to PMA (100 ng/ml)
for various times. At the indicated times, cells were processed for subcellular fractionation as described in Material and Methods.
Only the results for the distribution of PA are shown. The solid rectangles represent the specific activity of PA in the PNsup
applied to the gradient.
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Effect of PMAon Absolute Amounts of 75,000 and 49,000
Dalton Species PA Activity
Confluent monolayers were treated with PMA for the indicated times.
Lysates were collected and processed for SDS-PAGE as described. The
amounts of 75,000 and 49,000 dalton species PA activity recovered from
each gel were determined by the fibrinolytic assay. The data are reported as
a percentage of control Iysate, 75,000 or 49,000 dalton species PA activity
measured at each time (mean t SE, n =12).
* Difference from untreated control value significant at P <0.05 level accord-
ing to analysis of variance (19) .
During the period of increased lysate activity (5-8 h, Fig. 1)
and increased activity in the plasma membrane-enriched frac-
tions (Fig. 3), the 49,000 dalton PA increased to 432% of
control levels, whereas the 75,000 dalton PA showed only
gradual increase. After 24 h, lysate and 75,000 dalton PA
activity were not significantly different from control levels. The
amount of 49,000 dalton PA declined, yet remained 332% of
control. Therefore, PMA modulates the expression of activity
associated with both molecular weight forms.
Distribution of Molecular Weight Species in
Subcellular Fractions
Because PMA induced an increase in the PA in plasma
membrane-enriched fractions and also induced a specific mo-
lecular weight species, an experiment was designed to deter-
mine whether there was a specificity for the 49,000 dalton
species in the plasma membrane-enriched fractions. The mo-
lecular weights of PA in the intracellular and plasma mem-
brane-enriched fractions, from control and PMA-treated cul-
tures, was determined (Fig. 4).
The results indicate that in control, 3-, and 16-h PMA-
treated cultures, there was virtually none of the 49,000 dalton
species present in the intracellular membrane fraction. The
majority of the 49,000 dalton species was found in the plasma
membrane-enriched fraction, whereas the majority of the
75,000 dalton activity was in the intracellular membrane frac-
tion. These results indicate a specificity for the subcellular
location of each form of PA.
DISCUSSION
There are several correlations between extracellular release of
PA and aggressive cell behavior (for review, see reference 10).
This has led to the suggestion that extracellular proteolytic
activity mediated through PA is an important component of
the processes of tissue remodeling, cell migration, and meta-
static growth. Very little is known about the regulation of PA.
In fibroblasts, the cell-associated enzyme has the solubility
characteristics of a membrane-associated protein, but the ex-
tracellular activity is soluble (3, 11, 12). The goal of the present
study was to extend our originalobservations on the correlation
between the predominance ofplasma membrane-associated vs.
intracellular activity and the metabolic activity ofthe cells. We
have shown that the increase in activity after PMA treatment
is accompanied by an increase in PA in plasma membrane-
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FIGURE 4
￿
Distribution of molecular weight species in subcellular
fractions. Confluent monolayers were treated with PMA for 3 or 16
h. Control and PMA-treated cells were then processed for subcel-
lular fractionation . The molecular weights of PA in the intracellular
membrane fractions (55%/35% sucrose interface) and the plasma
membrane-enriched fractions (22.5% dextran/19% sucrose interface)
of each gradient were then determined by SDS-PAGE. The maximum
percentage of hydrolysis for each gel was as follows: control 55/35,
38%; control 22.5/19,14%; PMA (3 h) 55/35,17%; PMA (3 h) 22.5/19,
13%; PMA (16 h), 55/35, 8%; PMA (16 h) 22.5/19,16%.
enriched fractions. This correlation leaves open the possibility
that PA mediates its effect on cellular behavior either as a
plasma membrane-associated ectoenzyme or as a soluble, ex-
tracellular enzyme.
The effects of PMA on cultured cells have been extensively
examined. The reported effects include decreased cell surface
fibronectin, increased sugar transport, increased saturation
density, altered morphology, and alterations in cell-to-cell re-
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24 128+20 111 t 19 332 t 59*lations and orientation that suggest that PMA causes temporary
changes including several aspects ofthe transformed orgrowing
phenotype (for a review, see reference 4). Under the conditions
used in these experiments, PMA is mitogenic and caused a
change in morphology to that characteristic of growing or
activated 3T3 cells (2). The results described here indicate that
PMA caused an increase in cell-associated PA that is due to
the induction of a 49,000 dalton species ofPA which was found
mostly in plasma membrane-enriched fractions. This may then
be the source of increased extracellular (either plasma mem-
brane-associated or noncell-associated) proteolytic activity, an
action that may result in cellular changes related to the mor-
phological change and increased activity ofPMA-treated cells.
This is strengthened by the fact that other mitogens such as
Ca" and serum also induced the 49,000 dalton species. In
addition, it was the major PA species in growing and trans-
formed 3T3 cells (3).
We cannot exclude the possibility that the increase in plasma
membrane-associated activity is due to readsorption of extra-
cellularly released PA. If this does occur, then the readsorbed
activity must be tightly associated with membrane components
as throughout the several washing steps of the gradient proce-
dure it resists being washed away and <I0% ofthe totalactivity
is recovered in the soluble fractions. Therefore, we feel that
nonspecific readsorption of PA to the cell surface cannot
explain the increased plasma membrane localization, but we
cannot eliminate the possibility ofa very tight, perhaps specific,
interaction.
In view of the current interest in the regulation of PA
production in transformed and untransformed cells, it is im-
portant to understand the relationship between the different
molecular weight forms. There are three possible alternatives
to consider: (a) The 75,000 and 49,000 dalton species are
separate gene products. Support for this hypothesis can be
found from the observation of Christman et al. (15) on the
effects of PMA on PA from hamster fibroblasts. They also
observed two molecular weight forms (75,000 and 50,000
daltons) and induction of only the 50,000 dalton species with
PMA. The 75,000 and 50,000 daltons were found to be im-
munochemically distinct and to differ in subunit size, which
may suggest that they are different polypeptides. (b) The 75,000
dalton is a precursor of the 49,000 dalton species. Another
alternative is that these two forms of PA are linked in a
precursor-product relationship and that PMA increases the rate
of conversion of 75,000 to 49,000 dalton PA. (c) The 49,000
dalton is a precursor of the 75,000 dalton species. The last
alternative is that the 49,000 dalton represents the initial gene
product which, after insertion into the plasma membrane,
would be available for association with a 26,000 dalton species.
It should be pointed out that an SDS-stable complex between
one form of PA (urokinase), and a cell-secreted factor has been
demonstrated (16). There is not enough evidence to distinguish
among the possibilities at the present time.
The observations presented in this papermay help to clarify
the relationship between the levels of PA in transformed cells
vs. theiruntransformed counterparts. Whereas previous studies
have demonstrated a strong correlation between increased
levels of PA and the expression ofthe transformed phenotype,
the current literature contains exceptions (13, 14, 17, see ref-
erence 18 for review). Thus, the increased PA levels in postcon-
fluent fibroblast monolayers compared with growing or trans-
formed cells should not be interpreted as providing evidence
for the lack ofimportanceofPA in transformation. In quiescent
cells, the activity is probably intracellular and unable to exert
influence on the cell surface. The levelof49,000 dalton plasma
membrane-associated activity is related to the metabolic activ-
ity of the cells. It is the presence of this form and not the level
of total lysate activity that may be related to some of the cell
surface characteristics ofgrowing and transformed cells which
can be influenced by proteolytic activity such as decreased
fibronectin, decreased adhesiveness, and increased cell migra-
tion.
We wish to thank ChristianaGeffen for expert technical assistance.
Receivedforpublication 1 December 1980, and in revisedform 13 April
1981.
REFERENCES
l. Quigley, J. P. 1979. Phorbol ester-induced morphological changes in transformed chick
fibroblasts: evidence for direct catalytic involvement ofplasminogen activator. Cell . 17:
131-141.
2. Jaken, S., and P. H. Black. 1981 . Correlation between a specific molecular weightform of
plasminogen activator and metabolic activity of3T3 cells. 90:721-726
3. Jaken, S., and P. H. Black. 1979, Differences in intracellular distribution ofplasminogen
activator in growing, confluent, and transformed 3T3cells. Proc. Nail . Acad Sci. U. S. A.
76:246-250.
4. Sivak, A. 1979. Cocarcinogenesis . Biocla'm. Biophys. Acia. 560:67-89.
5. Deutsch, D. G., and E. T. Mertz. 1970. Plasminogen : purification from human plasma by
affinity chromatography. Science (Wash. D.C.). 170:1095-1096.
6. Helkamp, T. W., R. L. Goodland, W. F. Bale, I. L. Spar, and L. E. Mutchles. 1960. High
specific activity iodination of -t-globulin with iodine-131 monochloride. Cancer Res. 20:
1495-1500.
7. Stanley, P., and J. P. Carver. 1977. Selective loss of wheat germ agglutinin binding to
agglutinin-resistant mutants of Chinese hamster ovary cells. Proc. Nail. Acad. Sci. U. S.
A. 74:5056-5059.
8. Graham, J. M., R. O. Hynes, E. A. Davidson, and D. F. Bainton. 1975. The location of
proteins labeled by the "I-lactoperoxidase system in the NIL8 hamsterfibroblast. Cell. 4:
353-365.
9. Sivak, A. 1972. Induction ofcell division: role ofcellmembrane sites. J Cell. Physiol . 80:
167-174.
10. Christman, J. K., S. C. Silverstein, and G. Acs. 1977. Plasminogen activators. In Research
Monographsin CellandTissue Physiology. A. J. Barrett, editor. North Holland Publishing
Co., Amsterdam. 90-149.
11. Christman, J. K., G. Acs, S. Silagi, and S. C. Silverstein . 1975. Plasminogen activator:
biochemical characterization and correlation with tumorigenicity. In Proteases and Bio-
logical Control . E. Reich, D. B. Rifkin, and E. Shaw, editors. Cold Spring Harbor
Laboratory, New York. Cold Spring Harbor, 827-846.
12. Quigley, J. P. 1976. Association of a protease (plasminogen activator) with a specific
membrane fraction isolated from transformed cells. J. Cell Biol . 71:472-486.
13. Loskutofl; D.J., and D. Paul. 1978. Intracellularplasminogen activator activityin growing
and quiescent cells. J. Cell . PhysioL 97:9-16.
14. Rohrlich, S. T., and D. B. Rifkin. 1977. Patterns ofplasminogen activator production in
cultured normalembryoniccells. J CellBiol. 75:31-42.
15. Christman, J. K., R. P. Copp, L. Pederinan, and C. E. Whalen. 1978. Specificity of
response inhamster cells inducedto produce plasminogen activatorby the tumorpromoter,
12-O-tetradecanoyl-phorbol-13-acetate . CancerRes. 38:3854-3860.
16. Baker, J. F., D. H. Low, R. L. Simmer, and D. D. Cunningham. 1980. Protease-nexin: a
cellular component that links thrombin and plasminogen activator and mediates their
binding to cells. Cell. 21 :37-45.
17. Wolf, B. A., and A. R. Goldberg. 1978. Lack ofcorrelation between tumorigenicity and
level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus. Proc.
Nail . Acad. Sci. U. S. A. 75:4967-4971.
18. Black, P. H. 1980. Shedding from the cell surface of normal and cancercells. Adv. Cancer
Res. 32:75-199.
19. Armitage, P. 1974. Statistical Methods in Medical Research. Blackwell Scientific Publi-
cations, Oxford, England. 3rd printing. 189-198.
)AKEN AND BLACK Regulation of Plasminogen Activator in 3T3 Cells
￿
731